Cogent Biosciences, Inc. (COGT) Social Stream
COGENT BIOSCIENCES INC (COGT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering COGT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 7 | $31 | $15 | $21.428 | $12.98 | 65.08% |
| 2022-02-08 | 7 | $31 | $14 | $20.571 | $12.98 | 58.48% |
| 2022-03-16 | 7 | $31 | $14 | $20.428 | $12.98 | 57.38% |
| 2022-05-10 | 6 | $23 | $14 | $19 | $12.98 | 46.38% |
| 2022-06-09 | 6 | $23 | $14 | $18.166 | $12.98 | 39.95% |
| 2022-06-17 | 6 | $23 | $15 | $18.333 | $12.98 | 41.24% |
| 2022-07-27 | 7 | $23 | $15 | $17.857 | $12.98 | 37.57% |
| 2022-08-08 | 7 | $23 | $15 | $18.571 | $12.98 | 43.07% |
| 2022-08-09 | 6 | $22 | $15 | $19.5 | $12.98 | 50.23% |
| 2022-11-02 | 5 | $28 | $15 | $20.5 | $12.98 | 57.94% |
| 2022-11-14 | 6 | $28 | $15 | $20.333 | $12.98 | 56.65% |
| 2022-12-12 | 6 | $28 | $15 | $20 | $12.98 | 54.08% |
| 2022-12-14 | 7 | $28 | $18 | $21.857 | $12.98 | 68.39% |
| 2023-02-07 | 7 | $28 | $18 | $22.142 | $12.98 | 70.59% |
The Trend in the Analyst Price Target
COGT's average price target has moved up $1.94 over the prior 25 months.
COGT reports an average of 132.38% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-28 | 6 | 23 | 14 | 19.000 | 6.510 | 191.86% |
| 2022-06-01 | 6 | 23 | 14 | 18.166 | 4.255 | 326.93% |
| 2022-08-08 | 7 | 23 | 15 | 18.571 | 12.600 | 47.39% |
| 2023-01-05 | 7 | 28 | 18 | 22.142 | 12.000 | 84.52% |
| 2023-01-26 | 7 | 28 | 18 | 22.142 | 14.750 | 50.12% |
COGT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 6 | 1 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 92 days, COGT's average broker recommendation rating worsened by 0.14.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, COGENT BIOSCIENCES INC's average analyst price target is higher than 440.82% of them.
- In the context of all US stocks, COGENT BIOSCIENCES INC's number of analysts covering the stock is greater than 632.08% of them.
- In terms of how COGENT BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 491.13% of that group.
- COGT has a lower variance in analysts' estimates than -601.74% of Pharmaceutical Products stocks.
Stocks similar to COGENT BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are UBX, FIXX, and BTAI.
View All Top Stocks by Price Target
Is COGT a Buy, Hold or Sell? See the POWR Ratings now!